You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

Home / Tests / Critical Infectious Diseases / Xpert MTB/RIF

Xpert® MTB/RIF

Two-hour detection of MTB and rifampin resistance mutations

Ordering Info

The Need

Great challenges face the global community, including the United States, with the worldwide re-emergence of TB and increased number of multi-drug resistant TB (MDR-TB) cases. The need for fast and accurate TB diagnosis with indication for the drug resistance is greater than ever.

Current MTB diagnostics methods require weeks to deliver a definitive result. Delayed results reporting can lead to patients placed in respiratory isolation unnecessarily or put on ineffective therapies. AFB smear could provide faster turn-around time, but may be missing the true positive cases and patients may continue to spread MTB to others in the community, increasing the disease burden.

The Solution

Xpert MTB/RIF, on-demand molecular testing — an ideal solution:

  • On-demand results that empowers physicians to manage patients effectively
  • As few as one negative result can be used in the decision to remove patient from respiratory isolation
  • Simultaneous detection of both MTB and rifampin resistance mutations, which are markers for MDR-TB strain
  • Acceptable samples include raw or concentrated sediments prepared from induced or expectorated sputum

The Impact

/Site Images/Tests/mtbrif-pathway-updated.png

Impact on Patient Isolation Pathway*

* Refer to the Xpert MTB/RIF package insert for details
^ Example with one Xpert® MTB/RIF negative result
# MOTT: Mycobacteria Other Than Tuberculosis; DST: Drug Susceptibly Test

Ordering Info

Xpert® MTB/RIF

Standard 10-Test Kit: GXMTB/RIF-US-10

Back to Top